Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis

Journal of Nuclear Cardiology

Volumn 19, Issue 3, 2012, Pages 438-447

  Kim, Jwa Kyung ^a   Kim, Sung Gyun ^a   Kim, Hyung Jik ^a   Song, Young Rim ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

Cardiac outcome; End stage renal disease; Risk stratification; Single photon emission computed tomography (SPECT)

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EVALUATION RESEARCH; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS PATIENT; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT INDICATION;

CARDIAC-GATED IMAGING TECHNIQUES; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PREVALENCE; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84864053088     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9497-2     Document Type: Article

References (31)

1. Baig SZ, Coats WC, Aggarwal KB, Alpert MA. Assessing cardiovascular disease in the dialysis patient. Adv Perit Dial 2009;25:147-54.
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006;17:2034-47. (Pubitemid 44036188)
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
4. KDOQI. Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49:S12-154.
5. Ruilope LM. The Framingham risk score is valuable in Europeans. Nat Rev Nephrol 2010;6:14-5.
6. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 2007;50:217-24. (Pubitemid 47031564)
7. Song YR, Kim SG, Kim EJ, Kim SJ, Park TJ, Song YS, et al. The prevalence of coronary artery disease in patients with end stage renal disease at the initiation of dialysis and the accuracy of noninvasive tests. Korean J Nephrol 2007;26:327-33.
8. Gimelli A, Rossi G, Landi P, Marzullo P, Iervasi G, L'Abbate A, et al. Stress/rest myocardial perfusion abnormalities by gated SPECT: Still the best predictor of cardiac events in stable ischemic heart disease. J Nucl Med 2009;50:546-53.
9. Piccini JP, Horton JR, Shaw LK, Al-Khatib SM, Lee KL, Iskan-drian AE, et al. Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death. Circ Cardiovasc Imaging 2008;1:180-8.
10. Kato M, Matsumoto N, Nakano Y, Suzuki Y, Yoda S, Sato Y, et al. Combined assessment of myocardial perfusion and function by ECG-gated myocardial perfusion single-photon emission computed tomography for the prediction of future cardiac events in patients with type 2 diabetes mellitus. Circ J 2011;75:376-82.
11. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hacha-movitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40. (Pubitemid 34049139)
12. Zellweger MJ, Lewin HC, Lai S, Dubois EA, Friedman JD, Ger-mano G, et al. When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: Implications of appropriate clinical strategies. J Am Coll Cardiol 2001;37:144-52. (Pubitemid 32051730)
13. Hatta T, Nishimura S, Nishimura T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 2009;36:1835-41.
14. Hakeem A, Bhatti S, Trevino AR, Samad Z, Chang SM. Non-invasive risk assessment in patients with chronic kidney disease. J Nucl Cardiol 2011;18:472-85.
15. Al-Mallah MH, Hachamovitch R, Dorbala S, Di Carli MF. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction. Circ Cardiovasc Imaging 2009;2:429-36.
16. Hase H, Joki N, Ishikawa H, Fukuda H, Imamura Y, Saijyo T, et al. Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant 2004;19:1161-7. (Pubitemid 38628136)
17. Momose M, Babazono T, Kondo C, Kobayashi H, Nakajima T, Kusakabe K. Prognostic significance of stress myocardial ECG-gated perfusion imaging in asymptomatic patients with diabetic chronic kidney disease on initiation of haemodialysis. Eur J Nucl Med Mol Imaging 2009;36:1315-21.
18. Venkataraman R, Hage FG, Dorfman T, Heo J, Aqel RA, de Mattos AM, et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angi-ography. Am J Cardiol 2008;102:1451-6.
19. Patel AD, Abo-Auda WS, Davis JM, Zoghbi GJ, Deierhoi MH, Heo J, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol 2003;92:146-51. (Pubitemid 36835962)
20. De Lima JJ, Wolff Gowdak LH, de Paula FJ, Ianhez LE, Franchini Ramires JA, Krieger EM. Validation of a strategy to diagnose coronary artery disease and predict cardiac events in high-risk renal transplant candidates. Coron Artery Dis 2010;21:164-7.
21. Wang JH, Kasiske BL. Screening and management of pretransplant cardiovascular disease. Curr Opin Nephrol Hypertens 2010;19: 586-91.
22. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003;108:1404-18. (Pubitemid 37174421)
23. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radio-nuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol 2009; 53:2201-29.
24. Aalten J, Peeters SA, van der Vlugt MJ, Hoitsma AJ. Is standardized cardiac assessment of asymptomatic high-risk renal transplant candidates beneficial? Nephrol Dial Transplant 2011;26:3006-12.
25. Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol 2007;100:1020-5. (Pubitemid 47368111)
26. Williams ME. Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: A nephrologist's perspective. Clin J Am Soc Nephrol 2006;1:209-20.
27. Singh M, Arora R, Kodumuri V, Khosla S, Jawad E. Coronary revascularization in diabetic patients: Current state of evidence. Exp Clin Cardiol 2011;16:16-22.
28. de Lemos JA, Hillis LD. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemod-ialysis. J Am Soc Nephrol 1996;7:2044-54. (Pubitemid 27468233)
29. Daemen J, Lemos P, Aoki J, Arampatzis C, Hoye A, McFadden E, et al. Treatment of coronary artery disease in dialysis patients with sirolimus-eluting stents: 1-year clinical follow-up of a consecutive series of cases. J Invasive Cardiol 2004;16:685-7.
30. Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 2003;14:2373-80. (Pubitemid 37052385)
31. Moroi M, Yamashina A, Tsukamoto K, Nishimura T. Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia. Int J Cardiol 2011.